Ratnakar Securities Pvt. Ltd.

SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE551.501.15 (+0.21 %)

PREV CLOSE ( ) 550.35

OPEN PRICE ( ) 539.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2960

TODAY'S LOW / HIGH ( )539.05 554.20

52 WK LOW / HIGH ( )441.1 810

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 23-02 2017

Management Info

R Ramakrishnan - Chairman Sandeep Rao - Managing Director

Registered Office

Address 9th Floor, â€˜ Cyber Oneâ€™, Unit No. 902,Plot No. 4 & 6, Sector 30 A,Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022 2789 2924 / 2789 3199

Email investors@solara.co.in

Website www.solara.co.in

Registrars Details

Cameo Corporate Services Ltd

Subramanian Buildings No 1 ,Club House Road,,Chennai

Listing : BSE, NSE

NEWS

04Dec Clarification On Volume Movement
Clarification in relation to the mail received from exchange on December..

19Nov USFDA completes inspection at Solara A
Solara Active Pharma Sciences (Solara) has successfully completed the in..

19Nov Solara Active Pharma Sciences informs
Solara Active Pharma Sciences has informed that it enclosed a press rele..

26Sep Clarification sought from Solara Acti
The Exchange has sought clarification from Solara Active Pharma Sciences..

16Aug Solara Active Pharma Sciences informs
Solara Active Pharma Sciences has informed regarding the receipt of firs..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	-100.8	-10.8000000000006
Gross Profit	-100.8	-10.8000000000006
Operating Profit	352.4	2129.8
Net Sales	3135.4	12837.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE) 5689.30 (1.38%)	M.Cap ( in Cr)68024.12
Abbott India (BSE) 28869.35 (0.15%)	M.Cap ( in Cr)61345.35
Glaxosmithkline Phar (BSE) 2543.10 (1.35%)	M.Cap ( in Cr)43081.65
Wockhardt (BSE) 1360.10 (2.16%)	M.Cap ( in Cr)22100.56
RPG Life Sciences (BSE) 2228.80 (1.27%)	M.Cap ( in Cr)3686.22

Shareholding Pattern

	PROMOTERS	42.01%
	NON-INSTITUTION	41.72%
	MUTUAL FUNDS/UTI	1.18%
	FI/BANKS/INSURANCE	0.03%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Mfg...	0.82
Motilal Oswal BSE H...	0.13
Bandhan BSE Healthc...	0.13
Aditya Birla SL Fle...	0.11
Motilal Oswal BSE 1...	0.01

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

SOLARA ACTIVE PHARMA SCIENCES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES